Caution must be taken when evaluating changes in expression levels and correlating that to immune responses, as PBMCs from human SLE patients showed increased expression of TLR9 mRNA and proteins compared with healthy controls. The gene discussed is TLR9; the disease is systemic lupus erythematosus.